Literature DB >> 19752031

Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1.

David Goulding1, Harold Thompson, Jenny Emerson, Neil F Fairweather, Gordon Dougan, Gill R Douce.   

Abstract

Currently, the Golden Syrian hamster is widely considered an important model of Clostridium difficile disease, as oral infection of this animal pretreated with antibiotics reproduces many of the symptoms observed in humans. Two C. difficile strains, B1 and 630, showed significant differences in the progression and severity of disease in this model. B1-infected hamsters exhibited more severe pathology and a shorter time to death than hamsters infected with 630. Histological changes in the gut did not correlate with absolute numbers of C. difficile bacteria, but there were clear differences in the distribution of bacteria within gut tissues. Light, scanning, and transmission electron microscopy revealed high numbers of B1 bacteria at the mucosal surface of the tissue, whereas 630 bacteria were more frequently associated with the crypt regions. Both B1 and 630 bacteria were frequently observed within polymorphonuclear leukocytes, although, interestingly, a space frequently separated B1 bacteria from the phagosome wall, a phenomenon not observed with 630. However, pilus-like structures were detected on 630 located in the crypts of the gut tissue. Furthermore, B1 bacteria, but not 630 bacteria, were found within nonphagocytic cells, including enterocytes and muscle cells.

Entities:  

Mesh:

Year:  2009        PMID: 19752031      PMCID: PMC2786451          DOI: 10.1128/IAI.00551-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

Review 1.  Type IV pili and twitching motility.

Authors:  John S Mattick
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

2.  Clostridium difficile infection in hospitals: a brewing storm.

Authors:  Louis Valiquette; Donald E Low; Jacques Pépin; Allison McGeer
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

3.  Modified thiocarbohydrazide procedure for scanning electron microscopy: routine use for normal, pathological, or experimental tissues.

Authors:  L E Malick; R B Wilson
Journal:  Stain Technol       Date:  1975-07

4.  Infection of hamsters with epidemiologically important strains of Clostridium difficile.

Authors:  S P Sambol; J K Tang; M M Merrigan; S Johnson; D N Gerding
Journal:  J Infect Dis       Date:  2001-05-11       Impact factor: 5.226

5.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.

Authors:  J G Bartlett; A B Onderdonk; R L Cisneros; D L Kasper
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

6.  Binding of Clostridium difficile to Caco-2 epithelial cell line and to extracellular matrix proteins.

Authors:  Marina Cerquetti; Annalucia Serafino; Annalisa Sebastianelli; Paola Mastrantonio
Journal:  FEMS Immunol Med Microbiol       Date:  2002-02-18

7.  Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues.

Authors:  Emanuela Calabi; Franco Calabi; Alan D Phillips; Neil F Fairweather
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection.

Authors:  P Naaber; R H Mikelsaar; S Salminen; M Mikelsaar
Journal:  J Med Microbiol       Date:  1998-07       Impact factor: 2.472

9.  Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters.

Authors:  Michelle M Merrigan; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  J Infect Dis       Date:  2003-12-09       Impact factor: 5.226

10.  Colonization for the prevention of Clostridium difficile disease in hamsters.

Authors:  Susan P Sambol; Michelle M Merrigan; Janet K Tang; Stuart Johnson; Dale N Gerding
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226

View more
  38 in total

1.  Reutericyclin and related analogues kill stationary phase Clostridium difficile at achievable colonic concentrations.

Authors:  Julian G Hurdle; Amy E Heathcott; Lei Yang; Bing Yan; Richard E Lee
Journal:  J Antimicrob Chemother       Date:  2011-05-31       Impact factor: 5.790

Review 2.  Type IV pili in Gram-positive bacteria.

Authors:  Stephen Melville; Lisa Craig
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 3.  Cyclic diguanylate signaling in Gram-positive bacteria.

Authors:  Erin B Purcell; Rita Tamayo
Journal:  FEMS Microbiol Rev       Date:  2016-06-26       Impact factor: 16.408

4.  Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.

Authors:  Jhansi L Leslie; Sha Huang; Judith S Opp; Melinda S Nagy; Masayuki Kobayashi; Vincent B Young; Jason R Spence
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

5.  Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B.

Authors:  Patima Permpoonpattana; Huynh A Hong; Jutarop Phetcharaburanin; Jen-Min Huang; Jenny Cook; Neil F Fairweather; Simon M Cutting
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

6.  Identification, immunogenicity, and cross-reactivity of type IV pilin and pilin-like proteins from Clostridium difficile.

Authors:  Grace A Maldarelli; Leon De Masi; Erik C von Rosenvinge; Mihaela Carter; Michael S Donnenberg
Journal:  Pathog Dis       Date:  2014-02-18       Impact factor: 3.166

7.  Gastrointestinal localization of metronidazole by a lactobacilli-inspired tetramic acid motif improves treatment outcomes in the hamster model of Clostridium difficile infection.

Authors:  Philip T Cherian; Xiaoqian Wu; Lei Yang; Jerrod S Scarborough; Aman P Singh; Zahidul A Alam; Richard E Lee; Julian G Hurdle
Journal:  J Antimicrob Chemother       Date:  2015-08-18       Impact factor: 5.790

8.  Protective efficacy induced by recombinant Clostridium difficile toxin fragments.

Authors:  Rosanna Leuzzi; Janice Spencer; Anthony Buckley; Cecilia Brettoni; Manuele Martinelli; Lorenza Tulli; Sara Marchi; Enrico Luzzi; June Irvine; Denise Candlish; Daniele Veggi; Werner Pansegrau; Luigi Fiaschi; Silvana Savino; Erwin Swennen; Osman Cakici; Ernesto Oviedo-Orta; Monica Giraldi; Barbara Baudner; Nunzia D'Urzo; Domenico Maione; Marco Soriani; Rino Rappuoli; Mariagrazia Pizza; Gillian R Douce; Maria Scarselli
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

9.  Analysis of Bacterial Communities during Clostridium difficile Infection in the Mouse.

Authors:  Ekaterina G Semenyuk; Valeriy A Poroyko; Pehga F Johnston; Sara E Jones; Katherine L Knight; Dale N Gerding; Adam Driks
Journal:  Infect Immun       Date:  2015-08-31       Impact factor: 3.441

10.  Structure of Clostridium difficile PilJ exhibits unprecedented divergence from known type IV pilins.

Authors:  Kurt H Piepenbrink; Grace A Maldarelli; Claudia F Martinez de la Peña; George L Mulvey; Greg A Snyder; Leon De Masi; Erik C von Rosenvinge; Sebastian Günther; Glen D Armstrong; Michael S Donnenberg; Eric J Sundberg
Journal:  J Biol Chem       Date:  2013-12-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.